For the Inventor, By the Inventor

Enter assignee name

Sanofi Biotechnology

USPTO Granted Patents = 37

EPO Patents = 28

Trademarks = 31

Forward Citations = 228

Loading Chart...

Loading Chart...

82 inventors (with patents filed for the assignee):

Allen Radin (13 out of 22 patents)

Neil John Graham (10 out of 32 patents)

Jennifer D Hamilton (9 out of 10 patents)

4. Corinne Hanotin (7 out of 7 patents)

5. Laurence Bessac (7 out of 7 patents)

6. Gianluca Pirozzi (7 out of 7 patents)

7. Umesh Chaudhari (6 out of 6 patents)

8. William J Sasiela (5 out of 7 patents)

9. Namita A Gandhi (5 out of 10 patents)

10. Leda Mannent (4 out of 4 patents)

11. Ariel Teper (4 out of 4 patents)

12. Marius Ardeleanu (4 out of 4 patents)

13. Marie Baccara-Dinet (3 out of 3 patents)

14. Robert C Pordy (3 out of 10 patents)

15. Robert B Evans (3 out of 87 patents)

37 patents: Sort by Forward Citations

1. 12440562 - Method of treating an eye-related disorder by administering an anti-interleukin-4 receptor alpha (anti-IL-4Rα) antibody (2025-10-14),

2. 12440561 - Method of diagnosis and treatment of rheumatoid arthritis (2025-10-14),

3. 12398212 - Methods for treating or preventing asthma by administering an IL-4R antagonist (2025-08-26),

4. 12297279 - Compositions and methods for treating pain in subjects with rheumatoid arthritis (2025-05-13),

5. 12240898 - Monoclonal anti-IL-1RAcP antibodies (2025-03-04),

6. 12083176 - Human antibodies to PCSK9 for use in methods of treating particular groups of subjects (2024-09-10),

7. 12054552 - Humanized anti-IL-1R3 antibody and methods of use (2024-08-06),

8. 12024564 - Humanized anti-IL-1R3 antibodies (2024-07-02),

9. 11932692 - Methods of treating cancer pain by administering a PD-1 inhibitor (2024-03-19),

10. 11845800 - Methods for treating or preventing asthma by administering an IL-4R antagonist (2023-12-19),

11. 11771743 - Methods for preventing or treating allergy by administering an IL-4R antagonist (2023-10-03),

12. 11639392 - Anti-IL-1R3 antibodies for use in inflammatory conditions (2023-05-02),

13. 11603408 - Methods for treating skin infection by administering an IL-4R antagonist (2023-03-14),

14. 11504426 - Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist (2022-11-22),

15. 11498969 - Compositions and methods for treating juvenile idiopathic arthritis (2022-11-15),

Sanofi Biotechnology is a leading global pharmaceutical company specializing in biotechnology. With a focus on research, development, and manufacturing of innovative therapies, Sanofi Biotechnology aims to improve patient outcomes and address unmet medical needs. Their portfolio includes a wide range of biologic drugs, vaccines, and therapeutic solutions that target various diseases such as cancer, diabetes, and rare genetic disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

37 Patents

#145 in Paris

#601 in France

#17,724 in the World

Sanofi Biotechnology

Forward Citations = 228

82 inventors:

Allen Radin (13 out of 22 patents)

Neil John Graham (10 out of 32 patents)

Jennifer D Hamilton (9 out of 10 patents)

4. Corinne Hanotin (7 out of 7 patents)

5. Laurence Bessac (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…